Which hedge funds own OVID? OVID THERAPEUTICS INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
30 tracked hedge funds disclosed a position in OVID (OVID THERAPEUTICS INC) in their Q2 2026 13F filings, worth $173.5m in total. The largest holder by portfolio weight is Ally Bridge Group (NY) LLC at 2.2% of its book. 6 opened a new position this quarter: Stempoint Capital LP, Braidwell LP, Spark Investment Management LLC, Atom Investors LP. 9 exited: Diametric Capital, LP, Gsa Capital Partners LLP, Walleye Capital LLC.
30
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
6
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
9
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$25.3m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$4.7m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$173m
Combined value
Sum of the holders' reported positions in the security.
2.4%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.